BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38619252)

  • 1. Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.
    Schalkwijk HH; Shewakramani NR; Das K; Andrei G; Snoeck R
    Antimicrob Agents Chemother; 2024 May; 68(5):e0011024. PubMed ID: 38619252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergism of trifluorothymidine and ganciclovir against HSV-1.
    Hobden JA; Kumar M; Kaufman HE; Clement C; Varnell ED; Bhattacharjee PS; Hill JM
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):830-3. PubMed ID: 20861476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
    van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
    J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
    Neyts J; Andrei G; De Clercq E
    Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1.
    Nguyen PHA; Fukushi S; Yamada S; Harada S; Yoshikawa T; Kinoshita H; Kawahara M; Ogawa T; Ebihara H; Moi ML; Saijo M
    Microbiol Spectr; 2024 Jan; 12(1):e0309123. PubMed ID: 38095468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
    Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
    Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
    Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Mechanism of Acyclovir Resistance in Herpes Simplex Virus 1, Which Has a UAG Stop Codon between the First and Second AUG Initiation Codons.
    Nguyen PHA; Yamada S; Shibamura M; Inagaki T; Fujii H; Harada S; Fukushi S; Mizuguchi M; Saijo M
    Jpn J Infect Dis; 2020 Nov; 73(6):447-451. PubMed ID: 32611982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral susceptibility of recombinant Herpes simplex virus 1 strains with specific polymerase amino acid changes.
    Rose R; Brunnemann AK; Baukmann S; Bühler S; Fickenscher H; Sauerbrei A; Zell R; Krumbholz A
    Antiviral Res; 2021 Nov; 195():105166. PubMed ID: 34419483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.
    Meng Q; Hagemeier SR; Fingeroth JD; Gershburg E; Pagano JS; Kenney SC
    J Virol; 2010 May; 84(9):4534-42. PubMed ID: 20181711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase.
    Schalkwijk HH; Gillemot S; Reynders M; Selleslag D; Andrei G; Snoeck R
    J Antimicrob Chemother; 2022 Oct; 77(11):3153-3162. PubMed ID: 36059135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus resistance to antiviral drugs.
    Morfin F; Thouvenot D
    J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
    Burrel S; Deback C; Agut H; Boutolleau D
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4833-42. PubMed ID: 20733037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.
    Bestman-Smith J; Schmit I; Papadopoulou B; Boivin G
    J Virol; 2001 Apr; 75(7):3105-10. PubMed ID: 11238837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.